{
    "nctId": "NCT02946918",
    "officialTitle": "Levothyroxine Replacement With Liquid Gel Capsules or Tablets in Post-thyroidectomy Stage in Low Risk Differentiated Thyroid Cancer Patients",
    "inclusionCriteria": "* Age \\> 18 years\n* Presumed AJCC (American Joint Committee on Cancer) tumor Stage I or II\n* Planned total or near-total thyroidectomy\n* Planned goal TSH suppression 0.1-0.5 mU/L for at least 18 weeks postoperatively\n* Normal serum TSH within 12 months preceding surgery\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* AJCC Stage III or greater\n* Undifferentiated, Anaplastic or Medullary Thyroid Cancer\n* Planned postoperative TSH goal other than 0.1-0.5 mU/L\n* History of gastrointestinal malabsorption or gastric bypass surgery\n* Pregnancy\n* Use of medications that alter the absorption or metabolism of levothyroxine\n* Prior use of levothyroxine"
}